baber/WOPTO huggingface dataset:
Patent CY-1915-A (CY)
Title: Cyclosporins
Inventor: ROSENTHALER JOACHIM
IPC: C07K16/00
Filed: 1985-09-27
Abstract: Immunogenic conjugates comprising a carrier coupled to a cyclosporin having an activate coupling group, e.g. activated carboxy group, e.g. (i) [(O-succinimidooxysuccinyl)-Thr]<2>-Cyclosporine and (ii) [(N- epsilon -succinimidooxysuccinyl)-(D)Lys]<8>-Cyclosporine. The subject conjugates are useful for the generation of monoclonal antibodies capable of distinguishing between cyclosporins, e.g. Cyclosporine, and metabolites, e.g. Cyclosporins 17 and 18.
Patent DK-139281-A (DK)
Inventor: ROUY N
IPC: C07D263/58
Filed: 1981-03-27
Abstract: Process for the preparation of optionally hydroxymethylated 6-chlorobenzoxazolone, which consists in chlorinating and, if appropriate, hydroxymethylating benzoxazolone in a mixture of water and dioxane.
Patent DK-192990-A (DK)
Inventor: GRANDGEORGE MICHEL
IPC: A61K39/42
Filed: 1990-08-14
Abstract: Drug for the treatment or prevention by passive immunization of the HIV-infection and processes for preparation thereof. According to the invention, the drug consists of, or comprises, a preparation of anti-HIV gammaglobulins Ig6 and/or IgM of human origin without antibodies directed against glycoproteins of the HIV virus envelope and/or anti-CD4 antibodies.
Patent DK-200384-A (DK)
Inventor: SCHERER GEORGE WALTER
IPC: C03B37/025
Filed: 1984-04-18
Abstract: A method is disclosed for making a glass or ceramic product such as a glass core or cladding element of an optical waveguide preform by suspending a particulate oxide in a non-aqueous liquid vehicle to provide a stable fluid suspension of oxide particles and forming the suspension into the desired configuration; destabilizing and gelling the formed suspension by adding a gelling agent and drying the resulting gelled intermediate to provide an integral, essentially crack-free porous product having the configuration of the gelled intermediate; and finally consolidating the porous product by heating to sinter the porous product into a non-porous glass or ceramic product.
Patent DK-232484-A (DK)
Inventor: HENDRY JAMES WATSON
IPC: B29C44/04
Filed: 1984-05-10
Abstract: A process of producing an injection moulding of plastics material comprises introducing the plastics material in the form of a molten stream into a mould space, and at one or more selected positions injecting a predetermined, finite quantity of a non-plastics fluid under pressure into the stream of plastics material at a controlled rate, the fluid being injected through means (19;90) around which flows the stream of plactics material whereby the fluid is injected directly into the plastics material, the fluid thereafter flowing simultaneously with the plastics material between the mould surfaces to fill the mould space (12) and exerting a pneumatic pressure on the surrounding plastics material (8) to pressurise the plastics material outwardly towards the mould surfaces. 
<??>The invention further provides an apparatus for producing an injection moulding in accordance with the process, and an injection moulding produced thereby.
Patent DK-262089-A (DK)
Inventor: SEELICH THOMAS
IPC: A61K38/43
Filed: 1989-05-29
Abstract: The invention relates to a tissue adhesive in lyophilised form, which, besides fibrinogen and factor XIII and, where appropriate, other proteins and auxiliaries or additives, contains at least one biologically tolerated surfactant. It has been found that the presence of these biologically tolerated surfactants shortens the reconstitution time of lyophilised tissue adhesive compositions without adversely affecting the biochemical, mechanical or biological properties of the composition or the fibrin produced therefrom.
Patent DK-276986-A (DK)
Inventor: LOS MARINUS
IPC: C07D401/04
Filed: 1986-06-12
Abstract: The present invention provides a process for the preparation of herbicidal 2-(4,4-disubstituted-5-oxo-2-imidazolin-2-yl) benzoic, nicotinic and quinoline-3-carboxylic acids, esters and salts.
Patent DK-330588-A (DK)
Inventor: VINCENT MICHEL
IPC: A61P31/12
Filed: 1988-06-16
Abstract: Compounds of general formula: 
<IMAGE>
 in which:
 X denotes
 either an oxygen atom,
 or two hydrogen atoms;
 Y denotes
 either a hydrogen atom
 or a hydroxyl group;
 or Y denotes an amino group on condition that X denotes two hydrogen atoms.
 R denotes a hydrogen atom, an alkyl group of 1 to 6 carbon atoms in a straight or branched chain, optionally substituted by one or more hydroxyl, amino, mercapto, methylthio, carboxyl or aryl groups such as phenyl, pyridyl or thienyl. 
<IMAGE>
 denotes a nitrogen-containing polycyclic structure, their enantiomers, epimers and diastereoisomers and their addition salts with a pharmaceutically acceptable acid or base. 
<??>Medications.
Patent DK-425286-A (DK)
Inventor: ROUY NOEL
IPC: C07D263/00
Filed: 1986-09-05
Abstract: 3-hydroxymethyl-6-chloro-benzoxazolone with the formula <IMAGE> is prepared by reacting 6-chloro-benzoxazolone with formaldehyde, for example, in aqueous solution. This compound can be used as starting material in the preparation of insecticides of the phosalone type.
Patent DK-452585-A (DK)
Inventor: KJELLEBERG STAFFAN
IPC: C12N11/08
Filed: 1985-10-04
Abstract: Processes for the surface culture of eukaryotic and procaryotic cells on solid carriers. The growth cells are cultured on or in the presence of a solid carrier coated with surface active molecules which act as a major carbon- and energy source. The surface active molecules which have very low solubility in an aqueous solution, are hold in position at the solid surface by hydrophobic forces. The process can be considered as an immobilization of the surface active molecules. The surface active molecules include phospholipids, triglycerides, fatty acids, proteins, synthetic peptides and sterol. The aqueous medium can be any convenient medium without foetal calf serum or albumin-compounds or with reduced amounts of these. The invention also includes products for healing skin leasions.
Patent DK-478186-A (DK)
Inventor: JONSSON ULF ERIK
IPC: A61K31/135
Filed: 1986-10-07
Abstract: Controlled release preparation containing a number of beads comprising a salt of metoprolol as the main soluble component, a method for the production thereof and the use in the treatment of cardiovascular disorders.
Patent DK-512985-A (DK)
Inventor: RAYMOND RICHARD LAVERNE
IPC: B09B5/00
Filed: 1985-11-07
Abstract: @ The present invention provides a process in which oxygen and nutrients are effectively supplied to biota for stimulating the biooxidation of a compound within a subterranean formation characterized by introducing an aqueous solution of hydrogen peroxide into the subterranean formation at at least one site, the 24-hour average concentration of the hydrogen peroxide initially introduced being between 0.0001% and 0.1% and increasing the 24-hour average concentration of hydrogen peroxide with time at a rate sufficient to provide a corresponding increase in oxygen available to the biota within the subterranean formation but without providing a toxic environment to the biota, and increasing intermittently the hydrogen peroxide concentration introduced into the formation for a short time sufficiently to be toxic to biota at or closely adjacent to the site of introduction thereof thereby removing the biota and thus increasing the permeability of the formation at or adjacent to the site of hydrogen peroxide introduction.
Patent FI-840049-A (FI)
Inventor: KARLSSON LARS
IPC: F41H3/02
Filed: 1984-01-06
Abstract: The invention relates to a thermal camouflage comprising a strengthening layer (4), e.g. a woven material, on which a polyethylene film layer (1), metallized on one side, has been laminated with the aid of fusion adhesive (3). On lamination the surface is embossed such as to make it mat. Since the polyethylene is transparent for infrared, it has low self-radiation. By means of the metal layer (2) there is obtained radiation insulation so that the outer layer (1) is in a thermal equilibrium which is hardly affected, e.g. by a warm object which is covered with the material, and the outer layer has a low emission ability of about 0.6-0.8, depending on thickness and pigmentation. By applying further layers (5), patchy images may be obtained with infrared reproduction in the wavelength ranges of 3-5  mu m and 8-14  mu m.
Patent FI-841122-A (FI)
Inventor: VAN GEEL JOSEPHUS JOHANNES
IPC: H02G3/04
Filed: 1984-03-20
Abstract: A cable ladder comprising tuo parallel, relatively spaced beams (1) and rungs (2) arranged between them, wherein each beam is mainly formed by a profile of sheet material having a vertical (4) and a horizontal limb (3), the latter being provided with a vertical flange (5) having openings, at a distance from each of which the beam is provided with stop means, formed by a ridge (8) of the vertical limb (4) facing the flange (5), said ridge having a recess (9) opposite each flange opening for receiving the head of the rung, the beam being furthermore provided with means for locking the end part of each rung passed through an opening and in between the stop means, the locking means being formed by a horizontal strip (7) arranged on the flange (5), the free edge of which strip (7) can be inserted into a recess (12) of the rung (2) in order to ensure that a rigid connection between rungs and beams can be established and mounting of a cable ladder can be appreciably simplified and the cost price is reduced.
Patent FI-841429-A (FI)
Inventor: KOMPIS IVAN
IPC: C07D451/14
Filed: 1984-04-11
Abstract: The pyrimidine derivatives of formula I    <IMAGE>  I  wherein R1 is naphthyl, substituted naphthyl or substituted phenyl; R2 is hydrogen or lower alkoxy; and A is an optionally present ethylene or 1,3-propylene, and wherein the diaminopyridine group has the exo-configuration when A is present, are described. These compounds are useful as antibacterial agents, antimalarial agents and antitumor agents, and can be used in combination with sulfonamides in the control of bacterial infections.
Patent FI-841882-A (FI)
Inventor: KAPLAN JEAN-PIERRE
IPC: C07D307/12
Filed: 1984-05-10
Abstract: 1. Claims (for the contracting states : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE) Diphenylazomethines containing an esterified chain and corresponding to the formula (I)  see diagramm : EP0125975,P15,F1  in which X1 , X2 and X3 independently of one another each represent a hydrogen or halogen atom or a (C1-6 )alkyl radical, R represents a straight-chain or branched (C1-6 )alkyl radical, n represents an integer from 1 to 10 and R' represents a straight-chain or branched (C1-6 )alkyl radical, a (C3-6 )cycloalkyl(C1-4 )alkyl radical, a (C3-7 )cycloalkyl radical, a (C2-6 )alkenyl radical, a (C3-6 )alkynyl radical, a (C1-4 )alkoxy(C1-4 )alkyl radical, a hydroxy-(C1-4 )alkyl radical, a (C1-4 )alkoxy-[(C1-4 )alkoxy]m -(C1-4 )alkyl radical, in which m is an integer from 1 to 3, a (C1-4 )alkoxycarbonyl(C1-4 )alkyl radical, a tetrahydrofurylmethyl radical, a phenyl-(C1-4 )alkyl radical which can carry a halogen atom, or a (C1-4 )alkoxy radical. 1. Claim (for the contracting state AT) Process for the preparation of diphenylazomethines containing an esterified chain and corresponding to the formula (1)  see diagramm : EP0125975,P17,F1  in which X1 , X2 and X3 independently of one another each represent a hydrogen or halogen atom or a (C1-6 )alkyl radical, R represents a straight-chain or branched (C1-6 )alkyl radical, n represents an integer from 1 to 10 and R' represents a straight-chain or branched (C1-6 )alkyl radical, a (C3-6 )cycloalkyl (C1-4 )alkyl radical, a (C3-7 )cycloalkyl radical, a (C2-6 )alkenyl radical, a (C3-6 )alkynyl radical, a (C1-4 )alkoxy-(C1-4 )alkyl radical, a hydroxy-(C1-4 )alkyl radical, a (C1-4 )alkoxy[(C1-4 )alkoxy]m -(C1-4 )alkyl radical, in which m is an integer from 1 to 3, a (C1-4 )alkoxy-carbonyl-(C1-4 )alkyl radical, a tetrahydrofurylmethyl radical, a phenyl-(C1-4 )alkyl radical which can carry a halogen atom, or a (C1-4 )alkoxy radical, process characterised in that either a benzophenone (II) see diagramm : EP0125975,P17,F2  is reacted with the hydrochloride of an ester of an omega-amino-alkanoic acid (III) H2 N-(CH2 )n -COOR', HCl or an acid (IV)  see diagramm : EP0125975,P17,F3  is reacted with an alcohol R'OH (V) in the presence of carbonyldiimidazole, or an alkali metal salt of an acid (VI)  see diagramm : EP0125975,P18,F1 is reacted with a compound R'Y (VII), in which Y represents a halogen atom or a labil group, such as mesyl or tosyl, the radicals X1 , X2 , X3 , n, R and R' having the meanings given above.
Patent FI-861389-A (FI)
Inventor: GAROFF THOMAS
IPC: C08F10/00
Filed: 1986-04-01
Abstract: A catalyst component for an alpha-olefin alpha polymerization catalyst (comprising an organoaluminium compound, an external electron donor and a solid catalyst component obtained by reaction of a solid magnesium-containing carrier component with a titanium halogen compound) is prepared by the steps of:   (a) dissolving, or suspending, a magnesium compound soluble in ethanol or water; (b) adding to the solution a substantially stoichiometric quantity of hydrochloric acid; (c) drying the ethanolic solution of the magnesium component by periodic azeotropic distillation; (d) precipitating a solid carrier component from the ethanol solution; and (e) reacting the solid carrier components with a titanium halogen compound in the presence of an internal electron donor or without an electron donor. p
Patent FI-883837-A (FI)
Inventor: BODO GYOERGY
IPC: A23K1/00
Filed: 1988-08-18
Abstract: PCT No. PCT/HU87/00058 Sec. 371 Date Aug. 17, 1988 Sec. 102(e) Date Aug. 17, 1988 PCT Filed Dec. 18, 1987 PCT Pub. No. WO88/04552 PCT Pub. Date Jun. 30, 1988.The compounds of the Formula I   <IMAGE> (I) (wherein R is hydrogen or halogen) and pharmaceutically acceptable acid addition salts thereof are suitable for the prophylaxis of undesired and unfavorable symptoms (e.g. perspiration, nausea, vomiting, dizziness, etc.) which occur when healthy humans or mammal animals are subjected to unusual moving (e.g. during transportation on aeroplane, or vehicles, ships, etc.
Patent FI-893526-A (FI)
Inventor: HOGAN JOHN JAMES
IPC: C12Q1/6832
Filed: 1989-07-21
Abstract: The binding of a nucleic acid probe with its complementary sequence in a targeted, single stranded nucleic acid is affected by the secondary and tertiary structure of the target nucleic acid. The rate and extent of hybridization of the probe with the targeted nucleic acid can be increased by the use of "helper" oligonucleotides. Helper oligonucleotides are selected to bind to the target nucleic acid and impose a different secondary and tertiary structure on the target to facilitate the binding of the probe to the target. The resulting hybrid of probe and target nucleic acid also exhibits a higher Tm than the hybrid which results from addition of the probe alone.
Patent FI-904114-A (FI)
Inventor: NOUSIAINEN MARKO
IPC: G06F9/445
Filed: 1990-08-20
Abstract: The invention concerns a signal processor system and method for charging a program memory in a microprocessor. According to the invention the charging device of the program memory comprises a buffer device 2 connected to the memory bus 3, the outputs of which buffer device can be forced to a state of high impedance, and an external system 6 which can force the signal processor 1 to a RESET condition and is connected via the buffer device 2 to the abovementioned memory bus 3 for charging the program memory 2 from this external system. <IMAGE>
Patent FI-915246-A (FI)
Inventor: MORIN JEAN-XAVIER
IPC: B04C3/06
Filed: 1991-11-06
Abstract: Cyclone for separating, by centrifuging, a mixture of gas and solid particles into a particle-enriched fraction and a particle-depleted gas fraction, comprising a cylindrical shell (1) into which there opens tangentially a conduit (4) for introducing the mixture of gas and solid particles, an axial conduit (2) for removing the gas fraction, means (14), situated in the lower part of the cylindrical shell (1), for removing the particle-enriched fraction, means (10, 11) for introducing a gas used to fluidise the fraction enriched in solid particles into a dense bed (12), and means for heat exchange (13) between the dense fluidised bed formed (12) and a fluid to be vaporised and/or heated, and means (15, 16) allowing the level of the dense bed (12) to be regulated. 
<??>Cyclone for separating off solid particles with preliminary cooling of these particles and improved separation. 
<IMAGE>
Patent FI-921259-A (FI)
Inventor: BHOORI YOUSUF MOHAMMED
IPC: C08L77/00
Filed: 1992-03-24
Abstract: The present invention relates to a composition comprising at least one polyamide, a non-functionalized olefinic polymer, and a functionalized block copolymer, comprising poly(ethylene/butylene) mid-blocks and poly(styrene) end blocks. The composition preferably comprises a fibrous filler of reinforcement.
Patent FI-942769-A (FI)
Inventor: TERRETT NICHOLAS KENNETH
IPC: A61P37/08
Filed: 1994-06-10
Abstract: PCT No. PCT/EP92/02746 Sec. 371 Date May 6, 1994 Sec. 102(e) Date May 6, 1994 PCT Filed Nov. 27, 1992 PCT Pub. No. WO93/12095 PCT Pub. Date Jun. 24, 1993.Compounds of formula:    <IMAGE>  (I)  and pharmaceutically acceptable salts thereof wherein R1 is H, C1-C4 alkyl, C1-C4 alkoxy or CONR5R6; R2 is H or- C1-C4 alkyl; R3 is C2-C4 alkyl; R4 is H, C2-C4 alkanoyl optionally substituted with NR7R8, (hydroxy)C2-C4 alkyl optionally substituted with NR7R8, CH=CHCO2R9, CH=CHCONR7R8, CH2CH2CO2R9, CH2CH2CONR7R8, SO2NR7R8, SO2NH(CH2)nNR7R8 or imidazolyl; R5 and R6 are each independently H or C1-C4 alkyl; R7 and R8 are each independently H or C1-C4 alkyl, or together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, morpholino or 4-(NR10)-1-piperazinyl group wherein any of said groups is optionally substituted with CONR5R6; R9 is H or C1-C4 alkyl; R10 is H, C1-C3 alkyl or (hydroxy)C2-C3 alkyl; and n is 2, 3 or 4; with the proviso that R4 is not H when R1 is H, C1-C4 alkyl or C1-C4 alkoxy; are selective cGMP PDE inhibitors useful in the treatment of cardiovascular disorders such as angina, hypertension, heart failure and atherosclerosis.
Patent FI-943523-A (FI)
Inventor: MUELLER BERND
IPC: C07C233/18
Filed: 1994-07-27
Abstract: Carbamates of the formula I wherein B is a saturated or unsaturated heterocyclic group, and the other substituents are defined in the specification, and having crop protection properties.
Patent FI-943816-A (FI)
Inventor: BERGMANN ANDREAS
IPC: G01N33/543
Filed: 1994-08-19
Abstract: For the determination of antibodies (Ak), in particular of autoantibodies, such as human autoantibodies against thyroid peroxidase (hTPO), a procedure is adopted in which the antibodies to be determined are bound to a solid or undissolved phase in a conventional manner using unspecific binders and are then selectively labelled, for a subsequent measurement, by reaction with a crude antigen preparation (Ag) and a further, labelled antibody or antibody fragment (F(AK)*) which are specific for the antigen but are not bound, or not significantly bound, by the binder. The presence of the antibodies (AK) to be determined manifests itself in the form of a label bound to the solid or undissolved phase, the amount of said label being proportional to the amount of the antibodies to be determined in the sample.
Patent FI-944727-A (FI)
Inventor: MACOR JOHN EUGENE
IPC: A61K31/4427
Filed: 1994-10-07
Abstract: PCT No. PCT/EP93/00738 Sec. 371 Date Oct. 6, 1994 Sec. 102(e) Date Oct. 6, 1994 PCT Filed Mar. 25, 1993 PCT Pub. No. WO93/21177 PCT Pub. Date Oct. 28, 1993   <IMAGE>  (I)  Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 is a substituted alkylene; C3-C7 cycloalkyl optionally substituted with HO; C3-C6 alkenyl optionally substituted with aryl; C5-C7 cycloalkenyl; or C3-C6 alkynyl; R2 is H; halo; F3C; NC; R8R9NOC; a substituted alkylene; R8R9NO2S; R10S(O)m; R12CON(R11); R10SO2N(R11); R8R9NOCN(R11); R10O2CN(R11); R13(CH2)nCH=CH; or R7O are selective 5-HT1-like receptor agonists useful in the treatment of migraine, cluster headache, chronic paroxysmal hemicrania and headache associated with vascular disorders.
Patent FI-945259-A (FI)
Inventor: ALA-KAILA KARI
IPC: D21C3/24
Filed: 1994-11-08
Abstract: The present invention concerns an improvement of the continuous so-called Kamyr-cooking used in the wood processing industry, in particular the present invention concerns an improvement of washing capacity in the washing zone used in conjunction with the cited digester by introducing two different washing liquids to the washing zone of the digester according to the degree of purity. <IMAGE>
Patent FI-945434-A (FI)
Inventor: FLYNN GARY ALAN
IPC: A61P15/00
Filed: 1994-11-18
Abstract: The present invention relates to novel mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase.
Patent FI-950894-A (FI)
Inventor: BOCHIS RICHARD J
IPC: A61K38/25
Filed: 1995-02-27
Abstract: PCT No. PCT/US93/07791 Sec. 371 Date Apr. 18, 1995 Sec. 102(e) Date Apr. 18, 1995 PCT Filed Aug. 18, 1993 PCT Pub. No. WO94/05634 PCT Pub. Date Mar. 17, 1994There are disclosed certain novel compounds identified as benzo-fused lactams which promote the release of growth hormone in humans and animals. This property can be utilized to promote the growth of food animals to render the production of edible meat products more efficient, and in humans, to increase the stature of those afflicted with a lack of a normal secretion of natural growth hormone. Growth promoting compositions containing such benzo-fused lactams as the active ingredient therefore are also disclosed.
Patent FI-954365-A (FI)
Inventor: PARK CHUNG P
IPC: C08J9/14
Filed: 1995-09-15
Abstract: Disclosed is an ethylenic polymer foam structure comprising an ethylenic polymer material. The ethylenic polymer material contains a substantially linear ethylenic polymer having: a) a melt flow ratio, I10/I2, </=5.63; b) a molecular weight distribution, Mw/Mn, defined by the equation Mw/Mn </=(I10/I2)-4.63; and c) a critical shear rate at onset of surface melt fracture of at least 50 percent greater than the critical shear rate at the onset of surface melt fracture of a linear olefin polymer having about the same I2 and Mw/Mn. The foam structures have toughness and elasticity similar to those formed from conventional LLDPE without the poor dimensional stability and foam quality associated with those structures. The foam structures have foam quality similar to those made with conventional LDPE but with enhanced toughness and elasticity. Further disclosed is a process for making the above foam structure and making it in a foam bead form. Further disclosed is a process for making an article of the foam beads.
Patent FI-961105-A (FI)
Inventor: VAN DORSSELAER VIVIANE
IPC: C07D295/08
Filed: 1996-03-08
Abstract: This invention relates to novel statone antiviral analogs, to the processes and intermediates useful for their preparation and to their use as antiviral agents.
Patent FI-962236-A (FI)
Inventor: KU GEORGE
IPC: A61P31/04
Filed: 1996-05-28
Abstract: PCT No. PCT/US94/12575 Sec. 371 Date Jul. 3, 1996 Sec. 102(e) Date Jul. 3, 1996 PCT Filed Nov. 3, 1994 PCT Pub. No. WO95/14670 PCT Pub. Date Jun. 1, 1995The present invention relates to heterocyclic benzenesulfonylimine derivatives and their use as inhibitors of Interleukin-1 (IL-1) action. Such inhibitors are useful in the treatment of various disease states as disclosed herein including rheumatoid arthritis, multiple sclerosis, diabetes mellitus, atherosclerosis, septic shock and pulmonary fibrosis.